Southwest Skin Specialists, LTD

Southwest Skin Specialists, now known as U. S. Dermatology Partners, provides specialized dermatological services, including surgical and cosmetic dermatology, to address diverse skin health issues. Founded in 1989, Southwest Skin Specialists operates out of Phoenix, US, focusing on dermatological care.

The company was acquired by U. S. Dermatology Partners in August 2017, broadening its reach and resources. The company has engaged in one significant deal to date.

Southwest Skin Specialists, now operating as U. S. Dermatology Partners, offers a comprehensive range of dermatological services aimed at addressing various skin-related health concerns. Their core offerings include general dermatology, surgical and cosmetic dermatology, Mohs micrographic surgery, dermatopathology, and clinical research.

Each service is designed to provide effective solutions for conditions such as skin cancer, acne, and eczema, ensuring that patients receive personalized care. The company caters to a diverse patient base, including individuals seeking routine skin evaluations and those in need of specialized treatments, primarily in the Phoenix and Scottsdale markets. They also utilize an in-house Dermatopathology Laboratory to enhance diagnosis accuracy for skin specimens processed on-site. The revenue model for Southwest Skin Specialists is based on direct patient transactions for dermatological services rendered, including consultations and treatments billed directly to patients or their insurance providers.

Operating on a fee-for-service structure, patients pay for individual services, ensuring transparent pricing. Their revenue is sustained through direct-to-consumer services and partnerships with insurance companies, primarily generated from medical treatments and dermatological procedures. Following the acquisition in August 2017, U. S.

Dermatology Partners plans to leverage the resources gained to enhance its service offerings and expand its market presence. Specific growth strategies include the potential introduction of new dermatological services and geographic expansion into surrounding markets. The recent funding will support these initiatives by facilitating the development of new products and enhancing operational capabilities.